Clinical Trial Update: Single-portal Endoscopic Carpal Tunnel Release Versus Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing single-portal endoscopic carpal tunnel release to Knifelight for carpal tunnel syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carpal Tunnel Syndrome

Snippet

Sponsor: University of Ioannina | Conditions: Carpal Tunnel Syndrome | Phase 2 | Status: WITHDRAWN